Matches in Nanopublications for { ?s ?p "[Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_assertion description "[Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130016.RA3R4TkACLt7-_7jC-gPSlZgMAOWHNxcDL-ucY78f-iWU130_provenance.